Canandaigua National Corp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Canandaigua National Corp’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$380K	Buy	3,341 +7	+0.2%	+$581	0.06%	186
2022 Q3	$206K	Sell	3,334 -15	-0.4%	-$1.05K	0.04%	233
2022 Q2	$267K	Sell	3,349 -28	-0.8%	-$2.65K	0.05%	206
2022 Q1	$355K	Sell	3,377 -118	-3%	-$11.5K	0.05%	205
2021 Q4	$377K	Sell	3,495 -42	-1%	-$4.58K	0.06%	203
2021 Q3	$387K	Sell	3,537 -524	-13%	-$54.4K	0.06%	190
2021 Q2	$380K	Sell	4,061 -426	-9%	-$39.2K	0.06%	191
2021 Q1	$413K	Sell	4,487 -299	-6%	-$25.2K	0.07%	183
2020 Q4	$350K	Sell	4,786 -195	-4%	-$14.5K	0.06%	190
2020 Q3	$387K	Sell	4,981 -825	-14%	-$56.8K	0.07%	179
2020 Q2	$323K	Buy	+5,806	New	+$248K	0.06%	199

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canandaigua National Corp's HZNP Position: Q4 2022 in Review

Canandaigua National Corp increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 0.21% in Q4 2022, buying an estimated $581 and bringing the position to 3,341 shares worth $380K. The position accounts for 0.06% of the portfolio, ranked #186.

Canandaigua National Corp first reported a position in HZNP in Q2 2020 and has held it in 11 quarters since. The position peaked at $413K in Q1 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Canandaigua National Corp held 3,341 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $380K as of Q4 2022.
Canandaigua National Corp bought 7 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $581.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.06% of Canandaigua National Corp's portfolio in Q4 2022, its #186 holding.
Canandaigua National Corp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and has held it in 11 quarters since.
Canandaigua National Corp's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $413K in Q1 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Canandaigua National Corp's 13F filing for Q4 2022, filed 25 Jan 2023.